Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines

被引：0
作者：
Sevilay Batıbay
Rezan Koçak Ulucaköy
Zafer Günendi
Işıl Fidan
Gülendam Bozdayı
Feride Nur Göğüş
机构：
[1] Gazi University Hospital,Division of Rheumatology, Department of Physical Medicine and Rehabilitation
[2] Ministry of Health Ankara City Hospital,Department of Internal Medicine, Division of Rheumatology
[3] Gazi University Hospital,Medical Microbiology
来源：
Inflammopharmacology | 2022年 / 30卷
关键词：
Covid-19; SARS-CoV-2; Vaccine; CoronaVac; BNT162b2; Rheumatology; Inflammatory rheumatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2089 / 2096
页数：7
相关论文
共 50 条
  • [41] Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project
    Polewska, Karolina
    Tylicki, Piotr
    Biedunkiewicz, Bogdan
    Rucinska, Angelika
    Szydlowska, Aleksandra
    Kubanek, Alicja
    Rosenberg, Iwona
    Rodak, Sylwia
    Slizien, Waldemar
    Renke, Marcin
    Debska-Slizien, Alicja
    Tylicki, Leszek
    MEDICINA-LITHUANIA, 2021, 57 (07):
  • [42] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Murdoch, Louise
    Quan, Karen
    Baber, James A.
    Ho, Agnes W. Y.
    Zhang, Ying
    Xu, Xia
    Lu, Claire
    Cooper, David
    Koury, Kenneth
    Lockhart, Stephen P.
    Anderson, Annaliesa S.
    Tuereci, Ozlem
    Sahin, Ugur
    Swanson, Kena A.
    Gruber, William C.
    Kitchin, Nicholas
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2241 - 2258
  • [43] Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
    Louise Murdoch
    Karen Quan
    James A. Baber
    Agnes W. Y. Ho
    Ying Zhang
    Xia Xu
    Claire Lu
    David Cooper
    Kenneth Koury
    Stephen P. Lockhart
    Annaliesa S. Anderson
    Özlem Türeci
    Uğur Şahin
    Kena A. Swanson
    William C. Gruber
    Nicholas Kitchin
    Infectious Diseases and Therapy, 2023, 12 : 2241 - 2258
  • [44] Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study
    Heshin-Bekenstein, Merav
    Ziv, Amit
    Toplak, Natasa
    Lazauskas, Siman
    Kadishevich, Danielle
    Yaari, Efrat Ben-Nun
    Miller-Barmak, Adi
    Aviel, Yonatan Butbul
    Saiag, Esther
    Pel, Sara
    Elkayam, Ori
    Uziel, Yosef
    Furer, Victoria
    VACCINES, 2023, 11 (04)
  • [45] Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
    Mansanguan, Suyanee
    Charunwatthana, Prakaykaew
    Piyaphanee, Watcharapong
    Dechkhajorn, Wilanee
    Poolcharoen, Akkapon
    Mansanguan, Chayasin
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
  • [46] Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens
    Cotugno, Nicola
    Franzese, Enrica
    Angelino, Giulia
    Amodio, Donato
    Romeo, Erminia Francesca
    Rea, Francesca
    Faraci, Simona
    Tambucci, Renato
    Profeti, Elisa
    Manno, Emma Concetta
    Santilli, Veronica
    Rotulo, Gioacchino Andrea
    Pighi, Chiara
    Medri, Chiara
    Morrocchi, Elena
    Colagrossi, Luna
    Pascucci, Giuseppe Rubens
    Valentini, Diletta
    Villani, Alberto
    Rossi, Paolo
    De Angelis, Paola
    Palma, Paolo
    VACCINES, 2022, 10 (07)
  • [47] BNT162b2 COVID-19 Vaccine Safety among Healthcare Workers of a Tertiary Hospital in Italy
    Beccia, Flavia
    Regazzi, Luca
    Marziali, Eleonora
    Beccia, Viria
    Pascucci, Domenico
    Mores, Nadia
    Vetrugno, Giuseppe
    Laurenti, Patrizia
    VACCINES, 2023, 11 (02)
  • [48] The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience
    Revon-Riviere, Gabriel
    Ninove, Laetitia
    Min, Victoria
    Rome, Angelique
    Coze, Carole
    Verschuur, Arnauld
    de Lamballerie, Xavier
    Andre, Nicolas
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 30 - 34
  • [49] Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5-to 11-Year Olds
    Simoes, Eric A. F.
    Klein, Nicola P.
    Sabharwal, Charu
    Gurtman, Alejandra
    Kitchin, Nicholas
    Ukkonen, Benita
    Korbal, Piotr
    Zou, Jing
    Xie, Xuping
    Sarwar, Uzma N.
    Xu, Xia
    Lockhart, Stephen
    Cunliffe, Luke
    Lu, Claire
    Ma, Hua
    Swanson, Kena A.
    Koury, Kenneth
    Shi, Pei-Yong
    Cooper, David
    Tureci, Ozlem
    Jansen, Kathrin U.
    Sahin, Ugur
    Gruber, William C.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (04) : 234 - 238
  • [50] Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting
    Bieber, Amir
    Brikman, Shay
    Novack, Lena
    Abuhasira, Ran
    Fawaz, Abdallah
    Abu-Shakra, Mahmoud
    Zeller, Lior
    Ling, Eduard
    Mader, Reuven
    Sagy, Iftach
    RHEUMATOLOGY, 2023, 62 (10) : 3332 - 3338
12345